Even bipartisanship doesn’t guarantee success on drug pricing
Through one lens, the recently passed CREATES Act is a model of congressional harmony, a bipartisan bill to lower drug prices that came with industry support. So why’d it take 10 years to become law?
As STAT’s Nicholas Florko reports, the decade-long saga that got CREATES onto President Trump’s desk is a striking example of Congress’s modern dysfunction — and a chilling omen for more ambitious ideas to reduce the cost of medicine.
“The day it passed I was really fired up, and the next day I was like, ‘I can’t believe it took this long to get this done,’” said Michael Kades, the director for markets and competition policy at the Washington Center for Equitable Growth, who played a key role in drafting the CREATES Act.
Read more.
As STAT’s Nicholas Florko reports, the decade-long saga that got CREATES onto President Trump’s desk is a striking example of Congress’s modern dysfunction — and a chilling omen for more ambitious ideas to reduce the cost of medicine.
“The day it passed I was really fired up, and the next day I was like, ‘I can’t believe it took this long to get this done,’” said Michael Kades, the director for markets and competition policy at the Washington Center for Equitable Growth, who played a key role in drafting the CREATES Act.
Read more.
.png)
No hay comentarios:
Publicar un comentario